Literature DB >> 8095226

Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family.

T Ebner1, B Burchell.   

Abstract

Two cloned human hepatic UDP-glucuronosyltransferase (UGT) cDNAs were stably expressed in chinese hamster V79 cells. More than 100 drugs and xenobiotics were used as substrates for glucuronidation catalyzed by the cloned human transferases to determine the chemical structures accepted as substrates. UGT HP1 exhibited a limited substrate specificity for planar phenolic compounds, whereas UGT HP4 was more promiscuous in acceptance of non-planar phenols, anthraquinones, flavones, aliphatic alcohols, aromatic carboxylic acids, steroids, and many drugs of varied structure. Levels of HP4 UGT activity toward some substrates were sufficient to allow determination of kinetic parameters for the enzyme reaction. Metabolism of drugs could be studied by addition to the recombinant cell lines in culture, and extraction of the media allowed analysis of glucuronide formation. Data presented herein demonstrate the potential of using these recombinant cell lines for investigation of phase II metabolism by human UGTs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095226

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  20 in total

Review 1.  Glucuronidation in humans. Pharmacogenetic and developmental aspects.

Authors:  S N de Wildt; G L Kearns; J S Leeder; J N van den Anker
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

2.  Human UDP-Glucuronosyltransferases: Effects of altered expression in breast and pancreatic cancer cell lines.

Authors:  Centdrika R Dates; Tariq Fahmi; Sebastian J Pyrek; Aiwei Yao-Borengasser; Barbara Borowa-Mazgaj; Stacie M Bratton; Susan A Kadlubar; Peter I Mackenzie; Randy S Haun; Anna Radominska-Pandya
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

Review 3.  Glucuronidated Flavonoids in Neurological Protection: Structural Analysis and Approaches for Chemical and Biological Synthesis.

Authors:  Maite Docampo; Adiji Olubu; Xiaoqiang Wang; Giulio Pasinetti; Richard A Dixon
Journal:  J Agric Food Chem       Date:  2017-08-21       Impact factor: 5.279

4.  Contribution of UDP-glucuronosyltransferases 1A9 and 2B7 to the glucuronidation of indomethacin in the human liver.

Authors:  Yuji Mano; Takashi Usui; Hidetaka Kamimura
Journal:  Eur J Clin Pharmacol       Date:  2007-01-24       Impact factor: 2.953

5.  Developmental aspects of human hepatic drug glucuronidation in young children and adults.

Authors:  C P Strassburg; A Strassburg; S Kneip; A Barut; R H Tukey; B Rodeck; M P Manns
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

6.  A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation.

Authors:  Junjie Ding; Yi Wang; Weiwei Lin; Changlian Wang; Limei Zhao; Xingang Li; Zhigang Zhao; Liyan Miao; Zheng Jiao
Journal:  Clin Pharmacokinet       Date:  2015-03       Impact factor: 6.447

Review 7.  Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

8.  Cosegregation of intragenic markers with a novel mutation that causes Crigler-Najjar syndrome type I: implication in carrier detection and prenatal diagnosis.

Authors:  N Moghrabi; D J Clarke; B Burchell; M Boxer
Journal:  Am J Hum Genet       Date:  1993-09       Impact factor: 11.025

9.  Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation.

Authors:  S B Senafi; D J Clarke; B Burchell
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

10.  Induction of UDP-glucuronosyltransferase by the flavonoids chrysin and quercetin in Caco-2 cells.

Authors:  A Galijatovic; U K Walle; T Walle
Journal:  Pharm Res       Date:  2000-01       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.